D-1607-2014 Class II Terminated
FDA drug recall D-1607-2014 was initiated by Alvogen, Inc on Aug 28, 2014 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component. The recall status is terminated (terminated Apr 30, 2015). Affected quantity: 8,964 (100 Count) bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 1, 2014
- Initiation Date
- Aug 28, 2014
- Termination Date
- Apr 30, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,964 (100 Count) bottles
Product description
Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count bottles Rx Only. Manufactured by Norwich Pharmaceuticals Inc., Norwich, NY 13185 USA; Distributed by Alvogen Inc, Pine Brook NJ 07058 USA.
Reason for recall
Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component.
Distribution pattern
Nationwide
Code information
NDC #47781-0230-01; Lot # 453289; Exp 08/31/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1607-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026